Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
AOD-9604 has GRAS status but no drug approval and no proven weight loss efficacy
The cost of the drug or substance administered is not included
Insulin sensitivity Metabolic signaling influences how efficiently your cells take up and use glucose
AOD-9604 Adolescent (12 to 17) Dosing: What Clinicians and Parents Need to Know At a glance Regulatory status / No FDA approval for any indication or age group Typical research dose in adults / 250 to 500 mcg subcutaneous once daily (not validated in adolescents) Adolescent trial evidence / Zero published RCTs in the 12, 17 age group Key safety concern / Potential interference with growth-plate biology and pubertal GH axis Compounding status / Available only through 503A compounding pharmacies under prescriber order Primary preclinical evidence / Heffernan et al
US$ 20.63
US$ 22.28
US$ 23.47
US$ 25.69
US$ 25.79
